RE:RE:News killer for shorterIsn't Prometic working on a tiny molecule still better than 4050? If so, not easy for PLI to make a deal. As a big pharma, how would you make a deal with a business working on a product that might turn out to be in competition with the one you are invited to invest in?
Wondering....